TP53 and central nervous system cancer: Moreover, Hirose et al. [61] have studied the action of TMZ in gliomas and the role p53 might play by using U87 glioma cells that were either p53-wild-type or p53- deficient (by virtue of expression of the viral oncoprotein E6).